A first-in-human,phase 1 trial of the anti-DLL4antibody (OMP-21M18)targeting cancer stem cells (CSC)in patients with advanced solid tumors. Smith DC,Eisenberg P,Stagg R,Manikhas G,Pavlovskiy A,Sikic B,et al. Cl
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerBone and Cancer FoundationBone & Cancer Foundation
SmithD.C.EisenbergP.StaggR.ManikhasG.PavlovskiyA.EUROPEAN JOURNAL OF CANCER -SUPPLEMENT-SMITH ET AL.: ' A First-In-Human, Phase I Trial of the Anti-DLL4 Antibody (OMP-21 M18) Targeting Cancer Stem Cells (CSCs) ' PATIENTS WITH ADVANCED SOLID TUMORS., [Online] 10 November 2010, ...